<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01087099</url>
  </required_header>
  <id_info>
    <org_study_id>2008/322</org_study_id>
    <nct_id>NCT01087099</nct_id>
  </id_info>
  <brief_title>A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children</brief_title>
  <acronym>WORMCON</acronym>
  <official_title>A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ghent University, Faculty of Veterinary Medicine, Dpt of Virology, Parasitology and Immunology, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>World Health Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Commonwealth Scientific and Industrial Research Organisation, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queensland Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The three major Soil-Transmitted Helminths (STH), Ascaris lumbricoides, Necator
      americanus/Ancylostoma duodenal and Trichuris trichiura are among the most prevalent
      parasites worldwide. The objective of this multicentre international study is to define the
      efficacy of a single 400 milligram dose of albendazole (ALB) against these three STHs using a
      standardised protocol. The trial will be undertaken among school age children in seven
      countries - Brazil, Cameroon, Cambodia, Ethiopia, India, Tanzania (Zanzibar) and Vietnam -
      each with a different epidemiologic pattern of infection. A trial of this nature is urgently
      required because in spite of the wide usage of albendazole over the last 3 decades, there is
      still no key publication reporting the efficacy of the anthelmintic accurately, and to modern
      conventional standards, that can act as a central reference for the baseline efficacy. The
      latter is critically important because albendazole is now being used even more widely, as
      large scale mass treatment campaigns are being implemented in Africa and elsewhere, with the
      intention of reducing morbidity in children. Such large scale usage of a drug risks
      resistance developing, but resistance cannot be detected unless benchmark values for baseline
      efficacy are widely known.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of albendazole</measure>
    <time_frame>14 to 30 days after treatment</time_frame>
    <description>To determine the efficacy of albendazole, and this will be assessed by the reduction in parasite faecal egg counts between the pre- and post-intervention surveys. The latter will be conducted 14-30 days after treatment.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1750</enrollment>
  <condition>Infections With Soil-Transmitted Helminths (STH)</condition>
  <arm_group>
    <arm_group_label>Albendazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with albendazole</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albendazole</intervention_name>
    <description>Treatment with albendazole</description>
    <arm_group_label>Albendazole</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children should be infected with a minimum of 150 eggs/gram of any of the three
             species of STH (i.e. Ascaris or hookworms or Trichuris).

        Exclusion Criteria:

          -  Not willing to participate

          -  Unable to give samples for follow up

          -  Severe intercurrent medical condition

          -  Diarrhoea at first sampling
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jozef Vercruysse</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Ghent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto René Rachou, Fundação Oswaldo Cruz</name>
      <address>
        <city>Minas Gerais</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Pasteur in Cambodia, Clinical Pathology Unit</name>
      <address>
        <city>Phnom Penh</city>
        <country>Cambodia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre for Schistosomiasis and Parasitology, Faculty of Sciences, University of Yaoundé I</name>
      <address>
        <city>Yaounde</city>
        <country>Cameroon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Medical Laboratory Sciences and Pathology , College of Public Health and Medical Sciences, Jimma University</name>
      <address>
        <city>Jimma,</city>
        <country>Ethiopia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastrointestinal Sciences, Christian Medical College</name>
      <address>
        <city>Vellore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Public Health Laboratory</name>
      <address>
        <city>Zanzibar</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Institute for Malariology, Parasitology and Entomology</name>
      <address>
        <city>Hanoi</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Cambodia</country>
    <country>Cameroon</country>
    <country>Ethiopia</country>
    <country>India</country>
    <country>Tanzania</country>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2010</study_first_submitted>
  <study_first_submitted_qc>March 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2010</study_first_posted>
  <last_update_submitted>July 30, 2011</last_update_submitted>
  <last_update_submitted_qc>July 30, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Jozef Vercruysse</name_title>
    <organization>University Ghent</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Nematode Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albendazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

